CLINICAL_TRIALS
research
· 2025-08-08
Clinical Trial Update: Itraconazole to Prevent Recurrent Barrett's Esophagus [Phase 1]
Summary
Phase 1 trial evaluating itraconazole to prevent recurrence of Barrett's esophagus with dysplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Kansas Medical Center | Conditions: Barrett Oesophagitis With Dysplasia | Phase 1 | Status: ACTIVE_NOT_RECRUITING